C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
11/2004
11/25/2004	WO2004085479A3 Treatment of viral infections
11/25/2004	US20040236087 Moraxella(branhamella) catarrhalis antigens
11/25/2004	US20040235766 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/25/2004	US20040235740 Administered as antitumor, antimetastasis, anticarcinogenic and/or wound healing agent; tissue regeneration
11/25/2004	US20040235117 Fusion protein comprised of t umor necrosis factor, cartilage oligomeric and cartliage matrix protein domains for use in identifying modulator for treatment of infections, autoimmue, cell proliferative, neurodegenerative and inflammatory diseases
11/25/2004	US20040235102 Comprises adenosine triphosphate binding cassette membrane protein for use in identifying modulator which prevent transport of neurotoxic molecules; treating nervous system disorders
11/25/2004	US20040235095 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
11/25/2004	US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004	US20040234973 Using cytosine methylation to diagnose cancer disorders
11/25/2004	US20040234951 Chimeric chains that coding for proteins that induce effects directed against viruses
11/25/2004	US20040234554 Hepatitis B virus crosslinked with immunogens, epitopes; capsid peptide binding to core protein; vaccine
11/25/2004	US20040234536 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
11/25/2004	US20040234527 Peptides for use as translocation factors
11/25/2004	US20040234503 Materials and methods relating to improved vaccinations strategies
11/25/2004	US20040234498 Inducing apoptosis in mammalian cancer cellsl stimulanting a proinflammatory response ; polypeptides; tumor necrosis factor
11/24/2004	EP1479770A1 Surface expression libraries of randomized peptides
11/24/2004	EP1479694A2 Intrabodies ScFv with defined framework that is stable in a reducing environment
11/24/2004	EP1478927A2 Macromolecular conjugates and processes for preparing same
11/24/2004	EP1478777A2 Sequences specifically deleted from mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
11/24/2004	EP1478748A2 Fce fusion proteins for treatment of allergy and asthma
11/24/2004	EP1478747A1 Method for making purified plasminogen activator-inhibitor type 1 (pai-1) and purified pai-1 made therefrom
11/24/2004	EP1478405A2 Beta-homolysine conjugates and their use as transport enhancer
11/24/2004	EP1478393A2 Anti-pathogen treatements
11/24/2004	EP1478378A2 Anti-allergic complex molecules
11/24/2004	EP1390503A4 Novel nucleic acid molecules
11/24/2004	EP1381625B1 Mutants of green fluorescent protein
11/24/2004	EP1303539B1 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY
11/24/2004	EP1214340B1 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
11/24/2004	EP1137442B1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative
11/24/2004	EP1049787B1 Multipurpose antibody derivatives
11/24/2004	EP1003840A4 Synthetic genes for plant gums
11/24/2004	EP0551438B1 Surface expression libraries of randomized peptides
11/24/2004	CN1549826A Compositions and methods of treating diabetes
11/24/2004	CN1549727A Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments
11/24/2004	CN1548456A Specific liver gene and protein related to liver carcinoma differentiation and progression
11/24/2004	CN1177046C Enhanced virus-mediated DNA transfer
11/23/2004	US6822075 Protein for use in the diagnosis and treatment of autoimmune, cancer and viral disorders
11/23/2004	US6821519 Comprises polypeptide for detecting viral infection; immunoassays; immunostimulant
11/23/2004	CA2116026C Hepatitis c assay utilizing recombinant antigens to c-100 region
11/23/2004	CA2012482C Hepatitis c diagnostics and vaccines
11/18/2004	WO2004099418A1 Fused protein
11/18/2004	WO2002090499A3 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/18/2004	WO2002086087A3 Cytokine protein family
11/18/2004	US20040230051 Comprises nucleotide sequences coding b lymphocyte antigens for use as tool in prevention and treatment of cell proliferative disorders; immunotherapy
11/18/2004	US20040230032 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/18/2004	US20040229788 Cell surface molecule mediating cell adhesion and signal transmission
11/18/2004	US20040229277 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040229239 Comprises nucleotide sequences coding g-protein coupled receptors for identifying modulators of taste enhancement; food processing and drug design; screening tastants
11/18/2004	US20040229232 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040228798 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection
11/18/2004	DE19882755B4 Ein Fusionsprotein des hEGF und des humanen Angiogenins und ein Verfahren zu dessen Herstellung A fusion protein of hEGF and human angiogenin, and a process for its preparation
11/18/2004	CA2766627A1 Optimized fc variants and methods for their generation
11/18/2004	CA2524172A1 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses
11/17/2004	EP1477497A1 Humanized immunoglobulins and their production and use
11/17/2004	EP1476553A2 Gene for peripheral arterial occlusive disease
11/17/2004	EP1476541A2 Novel cytokine zcytor17 ligand
11/17/2004	EP1476460A2 A nucleic acid encoding a g-protein-coupled receptor; and uses thereof
11/17/2004	EP1476456A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/17/2004	EP1476180A2 Interleukin-2 mutants with reduced toxicity
11/17/2004	EP1476176A2 Transport peptides and uses therefor
11/17/2004	EP1337543A4 Streptavidin-binding peptides and uses thereof
11/17/2004	EP1180168B1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS
11/17/2004	EP0852502B1 Lantibiotic mutants and chimeras of enhanced stability and activity
11/17/2004	CN1547590A Humanized anti-LT-beta-R antibodies
11/17/2004	CN1546528A Fusion protein of kininogen D5 and tumor necrosis factor related apoptosis-inducing ligand(D5-TRAIL), its preparation and use thereof
11/17/2004	CN1546523A PEG poly-beta peptide and its preparation method
11/17/2004	CN1175900C CTLA-4 preparation for eyes
11/16/2004	US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004	US6818739 Somatostatins
11/16/2004	US6818443 Fluorescent proteins
11/16/2004	CA2074719C Calcium channel compositions and methods
11/11/2004	WO2004097416A1 Magnetic substance-biosubstance complex structure, peptide fragment capable of linking to magnetic substance and gene therefor, and process for structure
11/11/2004	WO2004096989A2 Single chain antigen-binding polypeptides for polymer conjugation
11/11/2004	WO2004020404A3 Modified transferin-antibody fusion proteins
11/11/2004	WO2003101394A3 Defensins: use as antiviral agents
11/11/2004	WO2003060150A8 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
11/11/2004	WO2003040695A3 Protein knobs
11/11/2004	WO2003012068A3 Novel fusion proteins and assays for molecular binding
11/11/2004	WO2002070665A3 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
11/11/2004	US20040223965 Hepatitis b core antigen fusion proteins
11/11/2004	CA2524071A1 Toll-like receptor 9 effector agents and uses thereof
11/11/2004	CA2521162A1 Single chain antigen-binding polypeptides for polymer conjugation
11/10/2004	EP1474528A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
11/10/2004	EP1474521A2 An herpes simplex virus complex
11/10/2004	EP1474451A2 De-immunized (poly)peptide constructs
11/10/2004	CN1544628A Trichina TS88 gene, their protein products and uses
11/10/2004	CN1544473A Recombinant fusion protein of mycobacterium tuberculosis Ag85B antigen and human IL-2, and its uses
11/10/2004	CN1544462A Heterologous expression of neisserial proteins
11/10/2004	CN1174998C Peptide immunogens for prevention and treatment of allergy
11/09/2004	US6814964 Supramolecules containing binding and therapeutic molecules bound to hybridized nucleic acids
11/09/2004	CA2273080C Mutants of the lag-3 proteins, products for the expression of these mutants and use
11/09/2004	CA2138137C Diphtheria toxin vaccines
11/09/2004	CA1341464C Hepatitis e, an enterically transmitted hepatitis viral agent
11/04/2004	WO2004095024A1 Probe for detecting and quantifying lipid second messenger and method of detecting and quantifying lipid second messenger using the same
11/04/2004	WO2004094620A2 Truncated baff receptors
11/04/2004	WO2004094476A2 Compositions and methods relating to stop-1
11/04/2004	WO2004093807A2 Somatostatin vectors
11/04/2004	WO2003103662A3 Inhibitors of glycoprotein vi
11/04/2004	WO2003062270A8 Fluorescent protein from aequorea coerulscens and uses therof
11/04/2004	US20040220088 Multiple domain glycoprotein hormones and methods of using

1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 295